Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE DENMARK EDITION 2026

Denmark’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Denmark. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Denmark
DK
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Denmark’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Denmark, snapshot 2 September 2026
Company
Symphogensymphogen.com$655.77M103
Adcendoadcendo.com$322.99M23
Hemabhemab.com$309.92M10
Minervaxminervax.com$255.82M7
Bavarian Nordicbavarian-nordic.com$184.97M5 roles35
IO Biotechiobiotech.com$175.33M15
NMD Pharmanmdpharma.com$174.33M26
Galecto Biotechgalecto.com$160.48M29
Lundbecklundbeck.com10 roles393Financial figure available in RadarView in Radar
Ascendis Pharmaascendispharma.com8 roles573
Genmabgenmab.com7 roles1,212Financial figure available in RadarView in Radar
WS Audiologywsa.com5 roles11,441
Commit Biologicscommitbio.com4 roles8
SNIPR Biomesniprbiome.com4 roles48
Fertin Pharmafertin.com3 roles850
3Shape3shape.com2,431
ALK-Abelloalk.net2,759Financial figure available in RadarView in Radar
Allarity Therapeuticsallarity.com7
ChemoMetecchemometec.com22Financial figure available in RadarView in Radar
Coloplastcoloplast.com12,578
Egaletegalet.com1Financial figure available in RadarView in Radar
Evaxion Biotechevaxion-biotech.com61
Orphazyme ApSorphazyme.com141
Zealand Pharmazealandpharma.com235Financial figure available in RadarView in Radar
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Life Sciences industry KPIs in Denmark

A few useful ratios bring the size of this ecosystem into perspective.

2 September 2026
Hiring participation8.3%

42 of 508 tracked companies have open roles.

Funding participation31.7%

161 of 508 tracked companies have a recorded round.

Top 3 funding share28.0%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$1.24M

Midpoint of 384 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 28.0% of disclosed capital, while 68.3% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Denmark life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Denmark life sciences
$0$180.95M$361.91M$542.86M$723.81M2016: $92.74M20162017: $102.69M20172018: $297.06M20182019: $338.79M20192020: $293.56M20202021: $634.92M20212022: $356.97M20222023: $483.71M20232024: $384.89M20242025: $339.78M2025
View the numbers
Annual life sciences funding and company formation in Denmark
YearFunding (USD)FoundedRaising
2016$92.74M2033
2017$102.69M3332
2018$297.06M3840
2019$338.79M2849
2020$293.56M1849
2021$634.92M1435
2022$356.97M1525
2023$483.71M1822
2024$384.89M1016
2025$339.78M313
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Symphogen14.3%
  • Adcendo7.0%
  • Hemab6.7%
  • Other companies72.0%

Funding by stage

417 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel149 35.7%
Series A–B116 27.8%
Series C+ / PE10 2.4%
Grants, debt & other142 34.1%

Recent recorded rounds

Latest recorded rounds · USD
3 rounds

Swipe or scroll horizontally to browse.

Seed05/2026
Alcolase $1.74M

Backed by Ada Ventures and Delphinus Venture Capital and others.

Series C04/2026
Adcendo $75M

Backed by Jeito and Vida Ventures and others.

Seed03/2026
Kvantify $8.12M

Backed by Europa and Delphinus Venture Capital.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series C10/2025
Hemabhemab.com$157M

Backed by Sofinnova Partners and Avoro Capital and others.

Series B02/2023
Hemabhemab.com$135M

Backed by Deep Track Capital and Avoro Capital and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
DKK · millions · standalone

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2018 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 11 reporting entities from 186 eligible matches.

Revenue in covered accountsDKK 16,479.1m

Sum of reporting-entity revenue; not Denmark market sales.

Net profit / lossDKK 3,583.1m

Combined result for the same cohort.

Aggregate net margin+21.7%

Combined net income ÷ combined revenue.

Median company revenueDKK 14.2m

The middle covered reporting entity.

Profitable entities+63.6%

7 of 11 covered entities.

Top-five concentration+99.9%

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2018 · 11 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

11 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
DENMARK · INDUSTRY COHORTS

How does life sciences compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Denmark companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

20 of these companies (3.9%) publish at least one Android app — 50 apps in all, carrying 11.2M installs between them.

AppInstallsRatingStore category
Signia AppWS Audiology3M2.7Medical
Oticon CompanionOticon1.9M4.2Medical
ReSound Smart 3DReSound1.7M4.4Medical
ReSound Tinnitus ReliefReSound895.8K4.5Health & Fitness
WIDEX MOMENTWS Audiology543.3K2.2Medical
Rexton AppWS Audiology541.4K2.6Medical
myRemoteWS Audiology396.2K2.6Medical
Audio Service AppWS Audiology384.1K3.5Medical
WIDEX TONELINKWidex351.6K3.3Medical
WIDEX EVOKEWidex194.9K2.8Medical

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q1–2026Q2).

SegmentAppsInstallsLeading appRelease trend
Assistive Tech2811MSignia App 3M
Ent Disorders2711MOticon Companion 1.9M
Disease Self Management132MPlatoApp 8.8K
Wearable Technology191.1MWIDEX TONELINK 351.6K
Dental Disorders271.1K3Shape Communicate 41.8K
Healthcare It99.2KCorPatch® 4.1K
Neurology39.1KEVY INSIGHT 264
Orthopedics48.8KIcura 5.9K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 32022Q4: 12022Q42023Q1: 12023Q1: 02023Q12023Q4: 12023Q4: 12023Q42024Q3: 22024Q3: 32024Q32025Q1: 12025Q1: 42025Q12025Q4: 22025Q4: 92025Q42026Q1: 12026Q1: 182026Q1

Darker bars are new releases, lighter bars apps updated. 36 of 50 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Denmark life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech312
Medical devices111
Biopharmaceuticals107
Healthtech94
Enterprise software66
Deep tech58
Consumer digital53
Saas22
Iot in healthcare19
Healthtech saas17
Chronic disease management17
In vitro diagnostics15

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

312companies
10.3%have hiring activity

32 companies hiring · $4.42B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce273
E-commerce - product228
Subscription152
Fee-for-service64
Commission on transaction7
Advertising4
E-commerce - service3
Licensing1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
IPO activityhemab.com ↗

Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG ), a clinical-stage biotechnology company ... today announced the closing of its initial public offering of 19,262,500 shares of its common stock at a public offering price of $18.00 per share, including 2,512,500 additional shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares.

Funding roundsadcendo.com ↗

Adcendo, a Copenhagen, Denmark-based developer of drugs designed to treat cancers with unmet medical needs, raised $75 million in Series C funding

Funding roundsallarity.com ↗

Allarity Therapeutics said on Friday it has closed a $20 million non-convertible debt financing transaction with venture capital firm Streeterville Capital.

Funding roundskvantify.com ↗

Kvantify has announced the successful second close of its funding round, bringing the total raised to €7 million ($8.1 million USD).

IPO activitygalecto.com ↗

Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers, today announced the closing of its previously announced underwritten public offering of 16,644,737 shares of its common stock, including the full exercise of the underwriters’ option to purchase up to 2,171,052 additional shares, at a public offering price of $19.00 per share.

Funding roundsbactolife.com ↗

The Danish company Bactolife has secured over 30 million euros in a series B financing round to market binding proteins, a new ingredient for food, feed and food supplements, which is produced by precision fermentation.

Funding roundsfidabio.com ↗

Fida Biosystems said this week that it has received €5 million ($5.9 million) in Series A investment from the Export and Investment Fund of Denmark (EIFO) and Swedish venture fund FSG.

Mergers & acquisitionsgenmab.com ↗

Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by Genmab Holding II B.V., a wholly owned subsidiary of Genmab (“Purchaser”), to acquire all the issued and outstanding common shares of Merus N.V. (Nasdaq: MRUS) (“Merus”) for $97 per common share in cash have been satisfied.

Mergers & acquisitionslundbeck.com ↗

Belgian drugmaker Lundbeck made an unsolicited, $23-per-share offer for Avadel Pharmaceuticals.

Full recorded event mix

Top 10 categories among 393 recorded events in the 24-month window.

Earnings
102
Funding rounds
63
Company announcements
44
Leadership moves
34
Mergers & acquisitions
32
IPO activity
26
Contracts
21
Board Updates
18
Capital infusions
16
Asset acquisitions
9
6 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

14 tracked people moves

LEO Pharma ↗
Matt Ferriday

Appointment General Manager for LEO Pharma UK

Stephanie S. Okey M.S.

Appointment Member of the Board of Directors

Oticon ↗
Michael Lamberson

Appointment president, US Wholesale

Paul Chaplin

Resignation Previously CEO

Lundbeck ↗
Richard Kim

Appointment SVP of neuro rare

3Shape ↗
Rasmus Hannemann

Appointment Senior Vice President, Portfolio & Product Strategy

Sherwin Sattarzadeh

Appointment Chief Operating Officer

IO Biotech ↗
Amy Sullivan

Appointment Principal Accounting Officer

Contract wins

13 recorded customer wins

Unibio ↗

Customer: saudi industrial investment groupAlternative protein

Symphogen ↗

Customer: Merck KGaA

Genmab ↗

Customer: medarexBiotechnology

Genmab ↗

Customer: janssen biotechBiotechnology

LEO Pharma ↗

Customer: astrazenecaPharmaceuticals

ALK-Abello ↗

Customer: Allergy Laboratories Inc. and Crystal Laboratory LLC

Litigation

5 tracked suits

Company
federal trade commission v lundbeck

antitrust concerning drug acquisitionsAntitrust · Dismissed

Company
morphosys v genmab, johnson & johnson

patent dispute over CD38-directed antibodiesPatent ·

Earnings pulse

Reported company results in the recorded window.

16companies
108period observations
14.0%median reported growth

Median across 31 reported growth observations; companies may contribute multiple periods.

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
origio a/sTrivector ScientificAnnounced2026-01-09Not stated in snapshot
GenmabmerusAnnounced2025-12-29$8.0B
Lundbeckavadel pharmaceuticalsAnnounced2025-11-21Not stated in snapshot
Galecto BiotechDamora Therapeutics, Inc.Announced2025-11-10Not stated in snapshot
rocheZealand Pharma ↗Completed2025-10-01$5.3B
Innosera ApSBavarian Nordic ↗Announced2025-08-07$2.9B

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

Recorded hiring and workforce signals from the available source snapshot.

Expand panel +

Most advertised job titles

No repeated job title is supported by this snapshot.

0 internship postings

0 tracked postings mention remote work.

THE PEOPLE BUILDING THE FIELD

Founders and leaders

476 founders and chief executives across 304 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

35 profiles with education records.

Copenhagen Business School
13
INSEAD
5
University of Oxford
4
Harvard Business School
2
Imperial College London
2
University of Cambridge
2
University of St.Gallen
1
IIT Bombay
1

Prior employers

5 profiles with prior-work records.

McKinsey
2
Microsoft
2
Bain
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

174,398 articles in the measured 12-month window.

Expand panel +
174,398articles in the measured year
27,676articles in 2026Q1
18.2%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Denmark · articles per complete quarter

030,58561,16991,754122,3382021Q2: 21,6502021Q22021Q3: 21,8752021Q4: 20,9212022Q1: 23,5812022Q2: 22,9242022Q22022Q3: 23,6022022Q4: 31,0032023Q1: 29,4252023Q2: 26,6582023Q22023Q3: 28,3142023Q4: 25,3062024Q1: 32,6822024Q2: 41,4712024Q22024Q3: 37,9052024Q4: 39,3172025Q1: 60,9602025Q2: 32,5382025Q22025Q3: 106,3812025Q4: 16,0162026Q1: 27,6762026Q1
View quarterly article counts
QuarterArticles
2021Q221,650
2021Q321,875
2021Q420,921
2022Q123,581
2022Q222,924
2022Q323,602
2022Q431,003
2023Q129,425
2023Q226,658
2023Q328,314
2023Q425,306
2024Q132,682
2024Q241,471
2024Q337,905
2024Q439,317
2025Q160,960
2025Q232,538
2025Q3106,381
2025Q416,016
2026Q127,676

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
22,846 positive · 30,146 neutral · 16,441 negative
2022
32,350 positive · 46,959 neutral · 21,698 negative
2023
32,975 positive · 59,321 neutral · 17,294 negative
2024
37,465 positive · 94,444 neutral · 19,363 negative
2025
39,188 positive · 148,944 neutral · 27,643 negative

Leading coverage topics

Life Sciences coverage across Denmark · ranked by full-period article count.

Geopolitical Disputes And Contested Areas278,785 articles in the full recorded period
108,073 recent · 81,373 prior
International And Transnational Geographic Entities278,783 articles in the full recorded period
108,072 recent · 81,374 prior
Administrative And Political Subdivisions278,755 articles in the full recorded period
108,065 recent · 81,365 prior
International Political Relations11,821 articles in the full recorded period
4,753 recent · 4,320 prior
International Sports Competitions10,234 articles in the full recorded period
1,937 recent · 2,143 prior
Security And Defense Policies7,770 articles in the full recorded period
3,203 recent · 2,535 prior
Nationalism And Sovereignty Debates5,071 articles in the full recorded period
2,107 recent · 2,477 prior
International Relations And Diplomacy4,382 articles in the full recorded period
1,765 recent · 1,262 prior
Olympic Games Coverage4,150 articles in the full recorded period
891 recent · 984 prior
Soccer Tournament Competitions4,091 articles in the full recorded period
663 recent · 1,024 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Denmark

KeywordRecentPriorChange
countries4,1891,858125%
geopolitical alliances81450262%
diplomatic strategies61938760%
tariff negotiations597255134%
multilateral diplomacy573185210%
foreign policy analysis422211100%
drone warfare311132292%
diplomatic engagements29420444%
national security strategy281108160%
study overseas27896190%
europa league119712-83%
quarterfinals153435-65%
final match79413-81%
olympic trials80232-66%
summit diplomacy96144-33%

Event and signal lenses

Life Sciences coverage across Denmark

All complete annual cohorts shown
Rising

Regulatory Risk

422,603 classified articles

territories, disputed islands, countries

6.6% critical · 5.0% positive
Rising

Funding Momentum

13,338 classified articles

quarterfinals, world cup, europa league

40.1% critical · 44.1% positive
Rising

Growth

16,600 classified articles

offshore wind farms, gdp growth rate, league expansion news

32.7% critical · 47.5% positive

Life Sciences coverage across Denmark. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Issues surrounding microbial hazards, nutritional quality, and health impacts of processed foods.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
Gene and mRNA Delivery in MedicineCommon problems researchers identify · 03

Gene and mRNA Delivery in Medicine

711 papers

15.8% of this theme group

Barriers to effective gene expression, mRNA therapeutics, and cell‑culture systems.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Limitations in fertiliser use, nutrient uptake, and breeding for resilient, high‑yield crops.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease and Pest ManagementCommon problems researchers identify · 05

Plant Disease and Pest Management

691 papers

15.3% of this theme group

Complexities of host‑pathogen interactions and integrated strategies for disease control.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Rising drug‑resistant microbes in humans, livestock, and the environment.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological Order IssuesCommon problems researchers identify · 07

Miscellaneous Biological Order Issues

423 papers

9.4% of this theme group

Broad, interdisciplinary concerns ranging from molecular pathways to societal impacts.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative StressCautions · 01

Cellular Toxicity and Oxidative Stress

379 papers

21.5% of this theme group

Potential adverse effects of nanomaterials and assays on cell viability and stress pathways.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection in Plant BreedingCautions · 02

Genomic Selection in Plant Breeding

257 papers

14.6% of this theme group

Uncertainties in applying predictive genomics to improve agricultural traits.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and Animal NutritionCautions · 03

Feed Additives and Animal Nutrition

245 papers

13.9% of this theme group

Risks and benefits of novel bioactive compounds in livestock diets.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminants and Regulatory SafetyCautions · 04

Food Contaminants and Regulatory Safety

240 papers

13.6% of this theme group

Need for careful assessment of emerging food additives and contaminants.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and Repair MechanismsCautions · 05

DNA Damage and Repair Mechanisms

239 papers

13.5% of this theme group

Challenges in interpreting gene‑expression changes linked to genomic instability.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Co‑Selection of Antimicrobial ResistanceCautions · 06

Co‑Selection of Antimicrobial Resistance

206 papers

11.7% of this theme group

Complex interactions between antibiotics, biocides, and heavy metals driving resistance.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance ManagementCautions · 07

Pesticide Resistance Management

199 papers

11.3% of this theme group

Uncertainties in dosing strategies and biological control to curb resistance.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechniquesOpportunities · 01

Advanced Antibody and Imaging Techniques

1,044 papers

17.4% of this theme group

Innovative uses of fluorescent antibodies and flow cytometry for in‑vivo studies.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Regulation for Therapeutic TargetsOpportunities · 02

Gene Regulation for Therapeutic Targets

1,032 papers

17.2% of this theme group

Promising approaches manipulating gene expression to control apoptosis and disease.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based FoodsOpportunities · 03

Functional Plant‑Based Foods

878 papers

14.6% of this theme group

Development of health‑promoting ingredients and antioxidants from plant sources.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetic and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Emerging tools detecting DNA methylation and miRNA for disease monitoring.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and PostbioticsOpportunities · 05

Novel Antimicrobials and Postbiotics

809 papers

13.5% of this theme group

Exploration of plant‑derived agents and microbial metabolites to combat resistance.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Improvement of Crop TraitsOpportunities · 06

Genetic Improvement of Crop Traits

717 papers

11.9% of this theme group

Leveraging germplasm and QTL analysis to boost yield and quality.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass and Biofuel StrategiesOpportunities · 07

Sustainable Biomass and Biofuel Strategies

697 papers

11.6% of this theme group

Utilising agricultural waste and microbes for eco‑friendly energy and products.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.7%
Promising30.4%37.2%
Breakthrough14.1%26.1%
Problem-identifying8.3%9.7%
Cautionary3.5%4.4%
Comparative2.4%3.9%
Critical1.0%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Denmark

Published patent filings in the recorded source window.

Expand panel +
19,977filings 2016–2025
5,693assignees
2,223peak annual filings

Filing momentum

06391,2781,9172,5562016: 1,87420162017: 2,1712018: 2,03320182019: 1,9892020: 2,21220202021: 2,2232022: 1,91520222023: 1,7772024: 1,83820242025: 1,9452025

Who files the most

Novozymes AS
9,758
NOVO Nordisk AS
3,971
Genmab AS
1,732
CHR Hansen AS
1,694
Dupont Nutrition Biosci APS
1,433
Bavarian Nordic AS
1,017
Zealand Pharma AS
989
Danisco
766
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Denmark: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 2 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon